Navigation Links
Scarred for Life? Synedgen Hopes Not
Date:6/4/2013

Claremont, CA (PRWEB) June 04, 2013

Because burns tend to heal slowly, become infected and remain inflamed, they can produce scars that are excessive, physically debilitating and functionally damaging. Each year in the US, more than 1 million burn injuries require medical attention. While over the last several decades advances in life saving technology have improved outcomes for burn patients, methods to prevent scar formation have not kept pace.

With support from the US Army Medical Research and Materiel Command, Synedgen is working to accelerate the burn healing process. This contract will expand Synedgen’s pipeline wound care portfolio and facilitate studies to further demonstrate the extent of Synedgen’s novel polysaccharide derivative to reduce inflammation and provide enhanced healing with the reduction of scarring. Funding will also support analysis of cellular mechanisms of scar formation and how the product mitigates this process.

“There is an urgent need to address wound healing and scar reduction in burn patients, and we are eager to continue our product development to improve outcomes for these patients,” stated Synedgen president Shenda Baker. “Synedgen’s product has been demonstrated in vivo and in vitro to reduce inflammation and infection in dermal wounds and to increase healing with significant reduction of scar tissue. The product is designed to control the inflammation, both due to tissue damage and to bacteria, and accelerate the regenerative environment to prevent the emergence of excessive scar formation.”

This work is supported by the US Army Medical Research and Materiel Command under Contract No. W81XWH-13-C-0053. The views, opinions and/or findings contained in this release are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.

About Synedgen

Synedgen Inc. is an innovative pharmaceutical company focused on developing novel therapies and products through its proprietary biomaterials technology platform. Product development is targeted to specifically address unmet needs for therapies to treat inflammation, damage or infection at dermal, pulmonary and gastrointestinal surfaces.

Synedgen’s Corporate Headquarters, Research Laboratories and Manufacturing Facility are in Claremont CA. Additional information can be found at Synedgen’s web site at http://www.synedgen.com

Read the full story at http://www.prweb.com/releases/2013/6/prweb10796834.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Synedgen’s Synoplex® Receives FDA Indexing for Use in the Treatment of Chronic Wounds in Pachyderms
2. Synedgen Announces Issuance of Patent to Optimize Animal Health
3. Synedgen Announces Effective Treatment Against Bacterial Biofilms in Minor Animal Species
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... Seattle, WA. (PRWEB) , ... May 27, 2016 , ... ... give a podium presentation at Life Science Innovation Northwest on June 2, 2016. The ... that demonstrates NeuMedics compound and propriety microemulsion can be successfully used as a topical ...
(Date:5/27/2016)... AZ (PRWEB) , ... May 27, 2016 , ... Weeks ... Morning News in Phoenix, Dr. Michael Fitzmaurice, hand surgeon and founder of the Fitzmaurice ... the practice. The Wrist MRI machine is a state-of-the-art technology and only 1 of ...
(Date:5/27/2016)... ... 2016 , ... PBI-Gordon Corporation is pleased to announce Dave Loecke has accepted ... career with PBI-Gordon, Dave has served in a wide variety of roles. His most ... and launch of many of PBI-Gordon’s most successful products. , “Dave has been essential ...
(Date:5/27/2016)... ... May 27, 2016 , ... Doctors in Italy, Japan, the ... on the BRCA-1 associated protein (BAP1) gene and its link to malignant mesothelioma. Surviving ... here to read the full article now. , The studies analyzed for the ...
Breaking Biology Technology:
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
(Date:5/20/2016)... 20, 2016  VoiceIt is excited to announce ... By working together, VoiceIt and VoicePass ... and VoicePass take slightly different approaches to voice ... security and usability. ... new partnership. "This marketing and technology ...
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
Breaking Biology News(10 mins):